Levetiracetam
- Product NDC
- 68001-114
- 11-digit product format
- 680010114
- Labeler code
- 68001
- Product ID
- 68001-114_4c3170a9-0612-f257-e063-6294a90a1f4a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levetiracetam
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA091399
- Marketing category
- ANDA
- Marketing start
- 2014-02-13
- Substance
- LEVETIRACETAM
- Active strength
- 750 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levetiracetam
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVETIRACETAM | 750 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 44YRR34555 |
| Rxcui | 807832, 846378 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68001-114-06 | Levetiracetam | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 24 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| HYDROGENATED COTTONSEED OIL | INACTIVE INGREDIENT | Z82Y2C65EA | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68001-114 | LEVETIRACETAM TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 23 | Current NDC, Legacy NDC, 1 package rows | 20250410_402b488c-1733-4bf7-a7a8-b60805b022c9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-114-06 | 68001011406 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-114-06) | 2014-02-13 | 0000-00-00 | No | No | Current |